Radiologic, Pathologic and Molecular Attributes of Two Types of Papillary Renal Adenocarcinomas

References

• Hellsten S, Berge T, Linell F, Wehlin L. Clinically unrecognized renal cell carcinoma: an autopsy study. Prog Clin Biol Res 1982; 100: 273–5.
   Google Scholar
• Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4–6.
   PubMed Web of Science ®Google Scholar
• Weidner N, Carroll P, Flax J, Blumenfeld W, Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143: 401–11.
   PubMed Web of Science ®Google Scholar
• Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL. Tumor angiogenesis in node negative breast carcinoma: relationship with epidermal growth factor receptor, estrogen receptor and survival. Breast Cancer Res Treat 1994; 29: 109–16.
   PubMed Web of Science ®Google Scholar
• Pritchard AJ, Chatterjee T, Wilkinson M, Powe DG, Gray T, Hewitt RE. Evidence for a weak angiogenic response to human colorectal cancers. Br J Cancer 1995; 71: 1081–6.
   PubMed Web of Science ®Google Scholar
• McLaughlin AP, Talner LB, Leopold GR, McCullough DL. Avascular primary renal cell carcinoma: varied pathologic and angiographic features. J Urol 1974; 111: 587–93.
   PubMed Web of Science ®Google Scholar
• Renshaw AA, Corless CL. Papillary renal cell carcino-ma. Histology and immunohistochemistry. Am J Surg Path 1995; 19: 842–9.
   PubMed Web of Science ®Google Scholar
• Mydlo JH, Bard RH. An analysis of papillary adeno-carcinoma of the kidney. Urology 1987; 30: 529–34.
   PubMed Web of Science ®Google Scholar
• Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Path 1997; 10: 537–44.
   PubMed Web of Science ®Google Scholar
• Renshaw AA, Zhang H, Corless CL, Fletcher JA, Pins MR. Solid variants of papillary renal cell carcinoma: clinicopathologic and genetic features. Am J Surg Path 1997; 21: 1203–9.
   Google Scholar
• Wills JS, Santos RM, Ashley PF. Renal papillary adenocarcinoma. Clin Radiol 1979; 30: 53–7.
   Google Scholar
• Bocsko S, Fromowitz FB, Bard RH. Papillary adeno-carcinoma of the kidney: a new perspective. Urology 1979; 14: 491–5.
   Google Scholar
• Molininie V, Dauge-Geffroy MC, Cochand-Priollet B, Vieillefond A. Tubulopapillary tumors of the kidney: a distinct entity with a discussed prognosis. Arch Anat Pathol 1992; 40(5-6): 261–5
   Google Scholar
• Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS. Papillary (chromophil) renal cell carcino-ma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Path 1997; 21: 621–5.
   PubMed Web of Science ®Google Scholar
• Gerharz CD, Ramp U, Olert J, Moll R, Storkel S, Marx N, Gabbert S. Cytomorphological, cytogenetic, and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type. Virchow's Arch 1994; 424: 403–9.
   Google Scholar
• Blath RA, Mancilla-Jiminez R, Stanley RJ. Clinical comparison between vascular and avascular renal cell carcinoma. J Urol 1976; 115: 514–19.
   PubMed Web of Science ®Google Scholar
• Bard RH, Mydlo JH, Freed SZ. Detection of tumor angiogenesis factor in adenocarcinoma of the kidney. Urology 1986; 27: 47–50.
   Google Scholar
• Mydlo JH, Heston WDW, Fair WR. Characterization of a heparin-binding growth factor from adenocarcinoma of the kidney. J Urol 1988; 140: 1575–9.
   Google Scholar
• Mydlo JH, Macchia RJ. Conditioned media from a renal carcinoma cell line demonstrates the presence of basic fibroblast growth factor. J Urol 1993; 150: 997–1001.
   PubMed Web of Science ®Google Scholar
• Mydlo JH, Michaeli J, Goldenberg A, Heston WDW, Fair WR. Expression of transforming growth factor alpha and epidermal growth factor receptor mRNA in neo-plastic and non-neoplastic renal tissue. Cancer Res 1989; 49: 3407–11.
   Google Scholar
• Thelen P, Hemmerlein B, Kugler A, Seiler T, Ozisik R, Kallerhoff M, Ringert RH. Quantification by competitive quantitation RT-PCR of VEGF-121 and VEGF-165 in renal cell carcinoma. Andean Res 1999; 19(2): 1563–5.
   Google Scholar
• Zbar G, Glenn I, Lubensky P, Choyke MM, Magnusson G, Bergerheim S, Petterson, T, Amin AB, Linehan ML. Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol 1995; 153: 907–12.
   PubMed Web of Science ®Google Scholar
• Zambrano NR, Lubensky IA, Merino MJ, Linehan WM, Walther MM. Histopathology and molecular genetics of renal tumors: toward unification of a classification system. J Urol 1999; 162: 1246–58.
   Google Scholar
• Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros J, Moch H, Reuter YE, Ritz E, Roos G, Schmidt D, Srigley JR, Storkel S, van den Berg E, Zbar B. The Heidelberg classification of renal tumors. J Path 1997; 183: 131–3.
   Google Scholar
• Kovacs G. Molecular genetics and diagnosis of renal cell tumors. Urologe-Ausgabe A 1999; 38: 433–41.
   PubMed Web of Science ®Google Scholar
• Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 987–9.
   Google Scholar
• Sorkel S. Epithelial tumors of the kidney. Pathological subtyping and cytogenetic correlation. Urologe-Ausgabe A 38: 425–32.
   Google Scholar
• Dal Cin P, Polito P, Van den Berghe H. Genetics of renal tumors (editorial). Pathologica 1998; 90: 101–7.
   Google Scholar
• Dal Cin P, Quade BJ, Weremowicz S, Morton CC, Pauwels P, Van Den Berghe H. Involvement of chromosomes 1 and 18 in renal cell tumors. Cancer Gen Cytogen 2000; 116: 54–8.
   Google Scholar
• van den Berg A, Dijkhuizen T, Draaijers TG, Hulsbeek MM, Maher ER, van den Berg E, Storkel S, Buys CH. Analysis of multiple renal adenomas and carcinomas suggest allelic loss at 3p21 to be a prerequisite for malignant development. Genes, Chrom Cancer 1997; 19: 228–32.
   PubMed Web of Science ®Google Scholar
• van den Berg E, Dijkhuizen T, Oosterhuis JW, Geurts van Kessel A, de Jong B, Storkel S. Cytogenetic classification of renal cell cancer. Cancer Genet Cytogen 1997; 95: 103–7.
   PubMedGoogle Scholar
• Van Poppel H, Vandendriessche H, Boel K, Mertens V, Goethuys H, Haustermans K, Van Damme B, Baert L. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. J Urol 1997; 158: 45–9.
   PubMed Web of Science ®Google Scholar
• Mydlo JH, Kral JG, Macchia RJ. Preliminary results comparing the recovery of basic fibroblast growth factor (FGF-2) in adipose and benign and malignant renal tissue. J Urol 1998; 159: 2159–63.
   Google Scholar
• Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA. Risk factors for renal cellcarcinoma. Results of a population based case-control study. Cancer Causes Control 1993; 4: 101–10.
   Google Scholar